Keywords: Seattle Genetics, Adcetris, Black box warning, PML, Hodgkin lymphoma, sALCL, USA, FDA

“Black box” warning for Seattle Genetics’ Adcetris

Article | 16 January 2012

Print This

US biotech Seattle Genetics (Nasdaq: SGEN) saw its shares fall 5.2% to $17.49 on Friday, after the company announced updates to the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in